Answers are grounded in this paper and cite their sources.
In vitro analysis evaluates antibacterial properties in Ayurvedic herbs, indicating potential alternative therapies.
Introduction: In the era of escalating antimicrobial resistance, medicinal plants offer promising alternatives for novel drug discovery. In vitro studies serve as crucial tools for evaluating the antimicrobial potential of plant-based compounds. This study focuses on the antimicrobial screening of three Ayurvedic medicinal herbs—Rubia cordifolia (Manjistha), Strychnos potatorum (Katak), and Operculina turpethum (Trivrit)—traditionally recognized for their therapeutic properties. Objectives: To evaluate the antimicrobial activity of the selected Vishaghna herbs by integrating traditional Ayurvedic principles with modern microbiological evidence, and to comparatively assess their efficacy against both Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli) bacterial strains through in vitro analysis. Methodology: Crude extracts were prepared using methanol, aqueous, and ethyl acetate solvents. The Broth Dilution Method was employed to assess in vitro activity against Staphylococcus aureus (Gram-positive) and Escherichia coli (Gram-negative). Minimum Inhibitory Concentration (MIC) was determined using spectrophotometric absorbance at 600 nm. Results: Strychnos potatorum showed the strongest antimicrobial effect, especially against E. coli, followed by Operculina turpethum. Rubia cordifolia exhibited minimal activity. Conclusion: The study confirms the in vitro antimicrobial efficacy of Strychnos potatorum and supports the continued exploration of ethnobotanical.
No takes yet. Share an insight, caveat, or question.
Prof. (Dr.) Khagen Basumatary2 Dr. Nikita Sarkar1* (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: